Methods Mentioned
BETA
dissection
transfections
transfection
ubiquitination
Assay
confocal microscopy
exome sequencing
RNA-Seq
PMA
Fluorescence-activated cell sorting
Software Mentioned
ImageJ
Summit
GSEA
Polyphen
Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
Cancer Control : Journal of the Moffitt Cancer Center
Alfonso Quintás-CardamaJorge Cortes
Leukemia Research
Il-Kang NaPhilipp le Coutre
Current Treatment Options in Oncology
Michael J Mauro
Postȩpy higieny i medycyny doświadczalnej
Olga Grzybowska-IzydorczykTadeusz Robak
Haematologica
Carlo Gambacorti-Passerini